Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-08-11

Clinical Trial Update: Effect of Isosorbide Mononitrate on Hypertension to Improve Left Ventricular Hypertrophy, Fibrosis and Myocardial Function [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating isosorbide mononitrate for hypertension to improve left ventricular hypertrophy, fibrosis, and myocardial function has been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isosorbide Mononitrate (isosorbide mononitrate)

Snippet

Sponsor: Corporal Michael J. Crescenz VA Medical Center | Conditions: Hypertension | Phase 2 | Status: WITHDRAWN